Referred to the House Committee on Energy and Commerce.
This bill prohibits any Federal funds from being used for the HHS Reproductive Healthcare Access Task Force announced January 21, 2022, or for any successor or substantially similar task force. The prohibition applies to all Federal funding and would bar support for that specific task force structure or closely similar entities.
Progressives emphasize harms to reproductive access and marginalized groups.
Relative to its intended legislative type, this bill is clear about its singular purpose but sparse in implementation, definitional, fiscal, and oversight detail.
This bill prohibits any Federal funds from being used for the HHS Reproductive Healthcare Access Task Force announced January 21, 2022, or for any successor or substantially similar task force.
The prohibition applies to all Federal funding and would bar support for that specific task force structure or closely similar entities.
The bill does not specify alternative funding uses or carve-outs.
Low-to-moderate chance: easy textual clarity but highly partisan subject and needs both chambers plus executive approval.
Relative to its intended legislative type, this bill is clear about its singular purpose but sparse in implementation, definitional, fiscal, and oversight detail.
Progressives emphasize harms to reproductive access and marginalized groups.
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize harms to reproductive access and marginalized groups.
Likely strongly opposed; views the bill as a targeted defunding of a federal initiative to improve reproductive healthcare access.
Sees the measure as reducing federal coordination on reproductive care and as an ideological restriction on health policy.
Some impacts are speculative given the bill's narrow language.
Mixed reaction: appreciates congressional control over appropriations but worries about vague language and unintended disruption to health services.
Sees legitimate oversight interest in executive task forces, yet concerned about broad 'substantially similar' phrasing.
Would seek clarifications to avoid service disruptions.
Generally supportive; views the bill as an appropriate use of Congress's spending authority to stop a federal 'pro-abortion' task force.
Sees it as aligning federal funding with pro-life priorities and limiting executive initiatives that promote abortion access.
May push for broader restrictions.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Low-to-moderate chance: easy textual clarity but highly partisan subject and needs both chambers plus executive approval.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize harms to reproductive access and marginalized groups.
Low-to-moderate chance: easy textual clarity but highly partisan subject and needs both chambers plus executive approval.
Relative to its intended legislative type, this bill is clear about its singular purpose but sparse in implementation, definitional, fiscal, and oversight detail.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.